Cancer Research

We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and R&D provides a unique lens on the future of oncology. While immune checkpoint inhibitors have revolutionized cancer treatment, the stark reality is that most patients don't respond, largely due

The remarkable success of cancer immunotherapy has long been attributed almost exclusively to the power of T cells, yet a groundbreaking investigation now reveals a previously hidden ally crucial to winning the fight against tumors. This research summary examines a pivotal study that challenges the

For the thousands diagnosed each year with triple-negative breast cancer, the treatment path has often been a brutal journey defined by the blunt instrument of chemotherapy, but a groundbreaking discovery is now illuminating a far more precise and strategic path forward. This particularly

For individuals living with debilitating genetic skin disorders, effective treatments have remained elusive, often limited to managing symptoms rather than addressing the root cause encoded in their DNA. A groundbreaking development from researchers at the University of British Columbia and the

As a Biopharma expert with a deep background in research, development, and the integration of technology in medicine, Ivan Kairatov offers a unique perspective on the intersection of patient experience and clinical outcomes. His insights bridge the gap between complex data and the real-world

Recent breakthroughs are fundamentally recasting our understanding of cancer, shifting the focus from a disease of uncontrolled cell division to one characterized by a profoundly altered and ravenous metabolism. At the heart of this new perspective is the discovery that malignant cells harbor a